Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population
1 other identifier
interventional
20
1 country
2
Brief Summary
The sponsor of this study, Owlet Baby Care, Inc., is comparing the accuracy of their pulse oximeter Sensor with the measurements of oxygen levels in newborns who are already being monitored with arterial blood samples. A minimum of 20, but up to 100 participants will be enrolled in a hospital environment and need to weigh 1500 grams or more. The purpose of the testing is to gather information on pulse oximeter readings taken by the Owlet OSS 3.0 Sensor and compare the readings to blood gas samples drawn by the medical staff. This will determine if the Owlet Sensor is accurate in newborns up to an age of 28 days after actual or expected delivery date. The Owlet OSS 3.0 is the Sensor component within the Owlet Dream Sock, an over the counter, noninvasive pulse oximeter which is currently FDA cleared in infants 1-18 months and between 6 and 30lbs, meant to be used in the home environment. The Owlet Sock is a fabric wrap that secures the Sensor to a baby's foot. The Sensor estimates the baby's SpO2, pulse rate, and measures movement level, and transmits the wearer's readings to the paired Base Station via low energy BlueTooth energy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2025
CompletedFirst Posted
Study publicly available on registry
January 13, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedAugust 14, 2025
August 1, 2025
4 months
January 7, 2025
August 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulse oximetry Accuracy - Root Mean Square
Accuracy of the Owlet OSS 3.0 Sensor SpO2 readings compared to simultaneous arterial saturation (SaO2) measurements from arterial blood gas samples as determined by a root mean square (ARMS) calculation.
48 hours
Secondary Outcomes (2)
Pulse oximetry Accuracy - Bias
48 hours
Pulse oximetry Accuracy - Precision
48 hours
Study Arms (1)
Owlet Arm
EXPERIMENTALAll study participants meeting inclusion criteria with no stated exclusions will wear the Owlet OSS 3.0 Sensor during the study intervention. The Owlet OSS 3.0 Sensor may be placed continuously on a study subject for up to 48 hours with rotation to the opposite foot every 8 hours per device labeling to enable noninvasive data collection during the subject's standard of care blood draws. The Owlet base station will be activated in order to transmit readings but will not provide any external alarms or live displays during the monitoring period. No display of readings from the assigned Owlet device will be made available to the participant or the investigators during the time of data acquisition.
Interventions
This study specifically evaluates the Owlet pulse oximetry sensor, which is specifically designed and FDA cleared for for infants, and whose accuracy is specifically being validated in the neonate population.
Eligibility Criteria
You may qualify if:
- Less than or equal to 44 weeks corrected gestational age
- Weight equal or greater than 1500g
- Subjects with standard of care (SOC) arterial blood sampling line already in place at time of enrollment, with anticipated arterial blood gas measurements as part of their plan of care
You may not qualify if:
- Subjects with underdeveloped skin as assessed by a study investigator and/or reported by the clinical care team
- Subjects with abnormalities (e.g., limb deformities, open wounds, severe edema) at the planned application sites that would interfere with system measurements
- Potential subjects on extracorporeal membrane oxygenation (ECMO) or other mechanical circulatory support
- Arterial line is placed in a preductal position with the potential of pulmonary to systemic shunting
- Subjects undergoing cooling protocol/therapeutic hypothermia
- Subjects who are deemed too clinically unstable by the Principal Investigator (PI), sub-investigator and/or clinical care team to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Owlet Baby Care, Inc.lead
- Children's of Alabamacollaborator
- University of Minnesotacollaborator
Study Sites (2)
University of Alabama Birmingham - Children's of Alabama
Birmingham, Alabama, 35233, United States
University of Minnesota Medical Center
Minneapolis, Minnesota, 55454, United States
Related Publications (3)
Okunlola OE, Lipnick MS, Batchelder PB, Bernstein M, Feiner JR, Bickler PE. Pulse Oximeter Performance, Racial Inequity, and the Work Ahead. Respir Care. 2022 Feb;67(2):252-257. doi: 10.4187/respcare.09795. Epub 2021 Nov 12.
PMID: 34772785BACKGROUNDSjoding MW, Dickson RP, Iwashyna TJ, Gay SE, Valley TS. Racial Bias in Pulse Oximetry Measurement. N Engl J Med. 2020 Dec 17;383(25):2477-2478. doi: 10.1056/NEJMc2029240. No abstract available.
PMID: 33326721BACKGROUNDWackernagel D, Blennow M, Hellstrom A. Accuracy of pulse oximetry in preterm and term infants is insufficient to determine arterial oxygen saturation and tension. Acta Paediatr. 2020 Nov;109(11):2251-2257. doi: 10.1111/apa.15225. Epub 2020 Mar 6.
PMID: 32043645BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Gwenyth Fischer, M.D.
University of Minnesota Medical Center
- PRINCIPAL INVESTIGATOR
Michael A Brock, M.D.
University of Alabama Birmingham - Children's of Alabama
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2025
First Posted
January 13, 2025
Study Start
August 1, 2025
Primary Completion
December 1, 2025
Study Completion
February 1, 2026
Last Updated
August 14, 2025
Record last verified: 2025-08